These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17428149)

  • 1. Arylamine N-acetyltransferases.
    Sim E; Westwood I; Fullam E
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):169-84. PubMed ID: 17428149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
    Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
    J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
    Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
    Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
    Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
    J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria.
    Rodrigues-Lima F; Dupret JM
    Biochem Biophys Res Commun; 2002 May; 293(2):783-92. PubMed ID: 12054539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.
    Sim E; Fakis G; Laurieri N; Boukouvala S
    Adv Pharmacol; 2012; 63():169-205. PubMed ID: 22776642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.
    Zhang N; Liu L; Liu F; Wagner CR; Hanna PE; Walters KJ
    J Mol Biol; 2006 Oct; 363(1):188-200. PubMed ID: 16959263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylamine N-acetyltransferases: from structure to function.
    Sim E; Walters K; Boukouvala S
    Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
    Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
    Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica.
    Martins M; Pluvinage B; Li de la Sierra-Gallay I; Barbault F; Dairou J; Dupret JM; Rodrigues-Lima F
    J Mol Biol; 2008 Nov; 383(3):549-60. PubMed ID: 18778714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the o-acetylation reaction of hydroxylated heterocyclic amines by human arylamine N-acetyltransferases: a computational study.
    Lau EY; Felton JS; Lightstone FC
    Chem Res Toxicol; 2006 Sep; 19(9):1182-90. PubMed ID: 16978022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
    Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacogenetics of NAT: structural aspects.
    Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
    Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
    Sim E; Abuhammad A; Ryan A
    Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.
    Fakis G; Boukouvala S; Kawamura A; Kennedy S
    Pharmacogenet Genomics; 2007 Mar; 17(3):181-8. PubMed ID: 17460546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylamine N-acetyltransferase I.
    Minchin RF; Hanna PE; Dupret JM; Wagner CR; Rodrigues-Lima F; Butcher NJ
    Int J Biochem Cell Biol; 2007; 39(11):1999-2005. PubMed ID: 17392017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
    Tsirka T; Boukouvala S; Agianian B; Fakis G
    Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes.
    Pluvinage B; Li de la Sierra-Gallay I; Kubiak X; Xu X; Dairou J; Dupret JM; Rodrigues-Lima F
    FEBS Lett; 2011 Dec; 585(24):3947-52. PubMed ID: 22062153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human acetyl CoA:arylamine N-acetyltransferase variants generated by random mutagenesis.
    Summerscales JE; Josephy PD
    Mol Pharmacol; 2004 Jan; 65(1):220-6. PubMed ID: 14722254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
    Cheon HG; Boteju LW; Hanna PE
    Mol Pharmacol; 1992 Jul; 42(1):82-93. PubMed ID: 1635555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.